Antidepressant scripts account for largest annual rise in items dispensed in the England

1 August 2012

According to a new report issues this week by the UK’s Health and Social Care Information Centre (HSCIC), just under 46.7 million prescriptions for antidepressants were dispensed in England in 2011; a 3.9 million item (9.1%) increase on 2010.

This is the largest rise in items of any of the 200 sections listed within the British National Formulary, which categorizes all prescribed drugs in England by chapter and section, based on therapeutic action.

The Central Nervous System chapter, which includes antidepressants and other sections relating to mental health and neurological conditions, also saw the biggest increase in items of any of the 15 chapters over the same period – with 172.4 million items dispensed; an 8.9 million item (5.4 per cent) rise on the previous year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical